Christopher Ogden, SVP, Finance and Accounting at CytomX Therapeutics, Inc. (CTMX), sold 2,971 shares at $2.09 ($6K) on 2024-03-19, disclosed to the SEC on 2024-03-21.
Open-market sale of $6k CTMX by SVP, Finance and Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CTMX | SELL | 2025-06-17 | $33K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $5K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $2K | — | Filing → |